Biological nanopores: Difference between revisions
Restore visible brand name to Nanopore Wiki Tag: Manual revert |
Expand Nanopore Wiki source page with structured educational content |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
<translate> | <translate> | ||
<!--T:1--> | <!--T:1--> | ||
[[File: | [[File:AHL_DNA.PNG|thumb|right|320px|Alpha-hemolysin and related protein pores are important biological nanopore systems.]] | ||
'''Biological nanopores''' is part of the Nanopore Wiki learning path. Biological nanopores are protein or macromolecular pores that provide reproducible nanoscale sensing structures. | '''Biological nanopores''' is part of the Nanopore Wiki learning path. Biological nanopores are protein or macromolecular pores that provide reproducible nanoscale sensing structures. | ||
| Line 13: | Line 13: | ||
<!--T:3--> | <!--T:3--> | ||
== Scientific basis == | |||
* Examples include alpha-hemolysin, MspA, CsgG, and engineered pore variants. | |||
* Their defined structures enable precise sensing regions and mutation engineering. | |||
* Interpretations should be tied to measurable quantities, experimental controls, and documented analysis settings. | |||
* Claims should distinguish direct observations from downstream inference. | |||
<!--T:4--> | |||
== Selection logic == | == Selection logic == | ||
{| class="wikitable np-knowledge-table" | {| class="wikitable np-knowledge-table" | ||
| Line 31: | Line 38: | ||
|} | |} | ||
<!--T: | <!--T:5--> | ||
== Typical applications == | == Typical applications == | ||
* Nanopore sequencing. | * Nanopore sequencing. | ||
| Line 37: | Line 44: | ||
* Mechanistic studies of pore-analyte interactions. | * Mechanistic studies of pore-analyte interactions. | ||
<!--T: | <!--T:6--> | ||
== | == Quality checks == | ||
* Record platform, pore or flow-cell type, chemistry, voltage or acquisition settings, and software versions. | |||
* Use negative controls, positive controls, and replicate measurements where the claim depends on specificity. | |||
* Report limitations such as noise, bias, sample degradation, pore instability, or model-dependent analysis. | |||
* Separate physical mechanism, signal-processing choice, and biological interpretation. | |||
<!--T:7--> | |||
== Interpretation limits == | |||
* Assuming a pore optimized for sequencing is ideal for every sensing task. | * Assuming a pore optimized for sequencing is ideal for every sensing task. | ||
* Ignoring protein storage, membrane composition, and insertion side. | * Ignoring protein storage, membrane composition, and insertion side. | ||
* | * A single result should not be generalized beyond the sample, protocol, instrument state, and analysis pipeline used. | ||
* Medical, legal, regulatory, or commercial decisions require domain-specific validation beyond this educational summary. | |||
<!--T: | <!--T:8--> | ||
== Related pages == | == Related pages == | ||
* [[Nanopore technology]] | * [[Nanopore technology]] | ||
| Line 50: | Line 65: | ||
* [[Nanopore sequencing]] | * [[Nanopore sequencing]] | ||
<!--T: | <!--T:9--> | ||
== References == | == References == | ||
* [https://en.wikipedia.org/wiki/Alpha-hemolysin Alpha-hemolysin] | * [https://en.wikipedia.org/wiki/Alpha-hemolysin Alpha-hemolysin] | ||
Latest revision as of 09:24, 15 July 2026
Biological nanopores is part of the Nanopore Wiki learning path. Biological nanopores are protein or macromolecular pores that provide reproducible nanoscale sensing structures.
Core concepts
- Examples include alpha-hemolysin, MspA, CsgG, and engineered pore variants.
- Their defined structures enable precise sensing regions and mutation engineering.
- They often require membranes, suitable buffers, and careful protein handling.
- Commercial sequencing pores combine pore proteins with motors and integrated flow cells.
Scientific basis
- Examples include alpha-hemolysin, MspA, CsgG, and engineered pore variants.
- Their defined structures enable precise sensing regions and mutation engineering.
- Interpretations should be tied to measurable quantities, experimental controls, and documented analysis settings.
- Claims should distinguish direct observations from downstream inference.
Selection logic
| Step | Description |
|---|---|
| 1 | Define whether the target is DNA, RNA, protein, peptide, or small molecule. |
| 2 | Match pore constriction, charge environment, and stability to the target. |
| 3 | Check available mutations, adapters, or recognition sites. |
| 4 | Validate insertion, single-pore state, and target-specific events. |
Typical applications
- Nanopore sequencing.
- Single-molecule recognition and biosensing.
- Mechanistic studies of pore-analyte interactions.
Quality checks
- Record platform, pore or flow-cell type, chemistry, voltage or acquisition settings, and software versions.
- Use negative controls, positive controls, and replicate measurements where the claim depends on specificity.
- Report limitations such as noise, bias, sample degradation, pore instability, or model-dependent analysis.
- Separate physical mechanism, signal-processing choice, and biological interpretation.
Interpretation limits
- Assuming a pore optimized for sequencing is ideal for every sensing task.
- Ignoring protein storage, membrane composition, and insertion side.
- A single result should not be generalized beyond the sample, protocol, instrument state, and analysis pipeline used.
- Medical, legal, regulatory, or commercial decisions require domain-specific validation beyond this educational summary.